NOVARTIS INDIA
Back to Cashflow Statement
|
NOVARTIS INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-64 Cr | ₹-121 Cr | ₹-30 Cr | ₹-36 Cr | ₹-37 Cr |
What is the latest Cash Flow from Financing Activities ratio of NOVARTIS INDIA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-64 Cr |
Mar2024 | ₹-121 Cr |
Mar2023 | ₹-30 Cr |
Mar2022 | ₹-36 Cr |
Mar2021 | ₹-37 Cr |
How is Cash Flow from Financing Activities of NOVARTIS INDIA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-64 Cr | Negative | |
Mar2024 | ₹-121 Cr | Negative | |
Mar2023 | ₹-30 Cr | Negative | |
Mar2022 | ₹-36 Cr | Negative | |
Mar2021 | ₹-37 Cr | - |
Compare Cash Flow from Financing Activities of peers of NOVARTIS INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NOVARTIS INDIA | ₹2,162.5 Cr | -2.3% | -5.9% | -13.8% | Stock Analytics | |
ADANI ENTERPRISES | ₹293,410.0 Cr | -1.8% | 10% | -16.4% | Stock Analytics | |
REDINGTON | ₹20,994.6 Cr | -4.1% | 10.5% | 48.4% | Stock Analytics | |
MMTC | ₹10,746.0 Cr | 2.9% | 11.2% | -12.8% | Stock Analytics | |
LLOYDS ENTERPRISES | ₹10,730.1 Cr | 1.9% | -1.6% | 55.5% | Stock Analytics | |
HONASA CONSUMER | ₹9,369.0 Cr | -1.5% | -4.6% | -34% | Stock Analytics |
NOVARTIS INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NOVARTIS INDIA | -2.3% |
-5.9% |
-13.8% |
SENSEX | 1.5% |
1.7% |
0.6% |
You may also like the below Video Courses